Ixekizumab linked to decrease in psoriasis-related sexual difficultiesDecember 14, 2014Psoriatic ArthritisPsoriasis
Oral tofacitinib scores against psoriasis in phase III trialDecember 10, 2014Psoriatic ArthritisPsoriasis
Few psoriatic arthritis patients achieve minimal disease activity on methotrexateDecember 5, 2014PsoriasisPsoriatic Arthritis
TNF-alpha blockers effective in sustaining reduced PsA activityDecember 5, 2014PsoriasisPsoriatic Arthritis
Psoriasis is independently associated with advanced liver fibrosisDecember 3, 2014Psoriatic ArthritisPsoriasis
Psoriasis: Brodalumab maintains efficacy through 144 weeksNovember 19, 2014Psoriatic ArthritisPsoriasis
Certolizumab achieves sustained skin improvement in psoriatic arthritisNovember 17, 2014Psoriatic ArthritisPsoriasis
Chronic inflammatory disease patients at greater risk of major CV eventsNovember 7, 2014PsoriasisPsoriatic Arthritis
Apremilast succeeds against nail, scalp, palmoplantar psoriasisNovember 3, 2014PsoriasisPsoriatic Arthritis
Psoriasis patients’ QOL improved with calcipotriene/betamethasoneOctober 31, 2014PsoriasisPsoriatic Arthritis